Published in Curr Hypertens Rep on January 01, 2015
Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension. J Clin Invest (2015) 1.51
Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J (2016) 0.87
Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats. Am J Physiol Renal Physiol (2016) 0.80
Immunity in arterial hypertension: associations or causalities? Nephrol Dial Transplant (2015) 0.78
New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon? Curr Hypertens Rep (2015) 0.78
Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation. Cardiology (2016) 0.76
Effects of Aspirin on Endothelial Function and Hypertension. Curr Hypertens Rep (2016) 0.75
Role of ultrasound and microbubble-mediated heat shock protein 72 siRNA on ischemia-reperfusion liver injury in rat. Int J Clin Exp Med (2015) 0.75
Molecular determinants of the adrenal gland functioning related to stress-sensitive hypertension in ISIAH rats. BMC Genomics (2016) 0.75
Do High Salt Microenvironments Drive Hypertensive Inflammation? Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Transglutaminase is a Critical Link Between Inflammation and Hypertension. J Am Heart Assoc (2016) 0.75
T-lymphocyte Kv1.3 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patients. Exp Ther Med (2017) 0.75
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 38.57
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 33.94
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Pattern recognition receptors and inflammation. Cell (2010) 21.05
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet (2006) 6.89
HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science (2009) 6.59
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature (2011) 6.21
Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A (2010) 5.59
Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol (2009) 4.90
TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature (2013) 4.74
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature (2013) 4.57
Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell (2007) 4.33
NLRs join TLRs as innate sensors of pathogens. Trends Immunol (2005) 4.12
Regulatory T cells: how do they suppress immune responses? Int Immunol (2009) 3.58
CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int (2006) 3.53
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology (2010) 3.51
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity (2013) 3.22
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension (2009) 3.06
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity (2013) 2.74
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol (2008) 2.57
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature (2010) 2.31
The inflammasome in pathogen recognition and inflammation. J Leukoc Biol (2007) 2.28
Re(de)fining the dendritic cell lineage. Nat Immunol (2012) 2.17
The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol (2010) 2.04
T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension (2011) 2.03
CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology (2011) 2.03
Development and function of TH17 cells in health and disease. J Allergy Clin Immunol (2009) 1.95
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation (2004) 1.81
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus (2004) 1.73
Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens (2011) 1.72
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation (2010) 1.68
The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res (2011) 1.64
Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs. Circ Cardiovasc Interv (2012) 1.62
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol (1997) 1.56
Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension (2010) 1.54
Sex differences in primary hypertension. Biol Sex Differ (2012) 1.37
Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res (2013) 1.35
The effects of TLR activation on T-cell development and differentiation. Clin Dev Immunol (2012) 1.33
Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension (2013) 1.32
TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm (2010) 1.32
Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension (2012) 1.31
Immune mechanisms in hypertension and vascular injury. Clin Sci (Lond) (2014) 1.30
Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol (2011) 1.29
Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. Arch Histol Cytol (1995) 1.25
Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol (2010) 1.25
Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci (Lond) (2012) 1.23
Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol (2009) 1.22
Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. Hypertension (2014) 1.19
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res (2012) 1.19
Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension (2001) 1.15
Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol (2013) 1.08
Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury. Am J Physiol Renal Physiol (2014) 1.07
Tumor necrosis factor-α: regulation of renal function and blood pressure. Am J Physiol Renal Physiol (2013) 1.05
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int (2013) 1.04
TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. J Endocrinol (2013) 1.02
An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies gene expression and is associated with essential hypertension. Eur J Hum Genet (2006) 1.02
High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. Mol Med (2013) 1.02
NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury. J Pharmacol Exp Ther (2013) 0.99
Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol (2013) 0.98
TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion. Am J Physiol Renal Physiol (2010) 0.98
CD40/CD40L system and vascular disease. Intern Emerg Med (2007) 0.98
Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia. Clin Sci (Lond) (2012) 0.98
Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension (2013) 0.98
Innate immune regulation by toll-like receptors in the brain. ISRN Neurol (2012) 0.97
Brain dendritic cells: biology and pathology. Acta Neuropathol (2012) 0.96
Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males. Am J Physiol Regul Integr Comp Physiol (2012) 0.95
The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease. Cardiol Res Pract (2012) 0.95
Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome. Antioxid Redox Signal (2013) 0.93
Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension (2012) 0.93
Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice. PLoS One (2012) 0.91
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction. Basic Res Cardiol (2013) 0.90
Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension. Cardiovasc Res (2013) 0.90
Female spontaneously hypertensive rats have a compensatory increase in renal regulatory T cells in response to elevations in blood pressure. Hypertension (2014) 0.89
Antroquinonol mitigates an accelerated and progressive IgA nephropathy model in mice by activating the Nrf2 pathway and inhibiting T cells and NLRP3 inflammasome. Free Radic Biol Med (2013) 0.89
Toll-like receptors: sensing and reacting to diabetic injury in the kidney. Nephrol Dial Transplant (2013) 0.89
The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms. Kidney Int (2014) 0.89
Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction. Clin Sci (Lond) (2012) 0.88
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care (2014) 0.88
CD4⁺CD25⁺Foxp3⁺ regulatory T cells suppress cardiac fibrosis in the hypertensive heart. J Hypertens (2011) 0.86
Toll-like receptors in atherosclerosis. Int J Mol Sci (2013) 0.86
Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension. Int J Rheumatol (2010) 0.85
Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function. Coron Artery Dis (2010) 0.84
Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res (2004) 0.83
CMV infection, TLR-2 and -4 expression, and cytokine profiles in early-onset preeclampsia with HELLP syndrome. Am J Reprod Immunol (2014) 0.82
Impaired function of dendritic cells deficient in angiotensin II type 1 receptors. J Pharmacol Exp Ther (2010) 0.82
The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis. Arthritis (2012) 0.81
Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study. Curr Med Res Opin (2012) 0.81
Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study. BMC Nephrol (2013) 0.81
Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension. Clin Exp Nephrol (2010) 0.81
Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2. Vasc Med (2007) 0.79
Assessment of mean platelet volume and soluble CD40 ligand levels in patients with non-dipper hypertension, dippers and normotensives. Clin Exp Hypertens (2014) 0.78
CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice. Endocrinology (2014) 0.78
Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice. Acta Pharmacol Sin (2013) 0.78
Dendritic cells in cardiovascular diseases: epiphenomenon, contributor, or therapeutic opportunity. Circulation (2013) 0.77
Potential role of Toll-like receptors in programming of vascular dysfunction. Clin Sci (Lond) (2013) 0.76
Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension. Cell Metab (2012) 2.18
Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension. Hypertension (2004) 2.14
T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol (2010) 1.84
The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest (2008) 1.82
Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol (2007) 1.57
Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am J Physiol Renal Physiol (2010) 1.46
Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol Heart Circ Physiol (2004) 1.44
Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol (2002) 1.34
Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension (2012) 1.31
Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2009) 1.19
CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney. Hypertension (2013) 1.16
Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol (2008) 1.15
Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC). Am J Physiol Renal Physiol (2011) 1.11
BN phenome: detailed characterization of the cardiovascular, renal, and pulmonary systems of the sequenced rat. Physiol Genomics (2006) 1.09
Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem (2013) 1.08
High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney. Hypertension (2010) 1.08
Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension. J Am Soc Nephrol (2013) 1.04
Role of L-arginine in nitric oxide production in health and hypertension. Clin Exp Pharmacol Physiol (2008) 1.02
MicroRNAs contribute to the maintenance of cell-type-specific physiological characteristics: miR-192 targets Na+/K+-ATPase β1. Nucleic Acids Res (2012) 1.01
Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice. Am J Pathol (2011) 1.00
Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol (2002) 1.00
Epigenomics of hypertension. Semin Nephrol (2013) 1.00
Amino acids as modulators of endothelium-derived nitric oxide. Am J Physiol Renal Physiol (2006) 0.94
Cationic amino acid transport in the renal medulla and blood pressure regulation. Hypertension (2002) 0.90
Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium. J Pharmacol Exp Ther (2013) 0.90
NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats. Antioxid Redox Signal (2010) 0.89
Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats. Hypertension (2008) 0.88
Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Transl Res (2011) 0.86
L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla. Am J Physiol Regul Integr Comp Physiol (2004) 0.86
Role of nitric oxide in regulation of the renal medulla in normal and hypertensive kidneys. Curr Opin Nephrol Hypertens (2002) 0.85
Contribution of NADPH oxidase to membrane CD38 internalization and activation in coronary arterial myocytes. PLoS One (2013) 0.85
Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Pflugers Arch (2011) 0.85
Acid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-β-synthase. PLoS One (2012) 0.83
Renal medullary circulation. Compr Physiol (2012) 0.81
Role of cellular L-arginine uptake and nitric oxide production on renal blood flow and arterial pressure regulation. Curr Opin Nephrol Hypertens (2013) 0.81
Autophagy maturation associated with CD38-mediated regulation of lysosome function in mouse glomerular podocytes. J Cell Mol Med (2013) 0.80
Assessment of renal function; clearance, the renal microcirculation, renal blood flow, and metabolic balance. Compr Physiol (2013) 0.79
Exogenous L-arginine attenuates the effects of angiotensin II on renal hemodynamics and the pressure natriuresis-diuresis relationship. Clin Exp Pharmacol Physiol (2014) 0.77
Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.77
Influence of elevated renin substrate on angiotensin II and arterial blood pressure in conscious mice. Exp Physiol (2005) 0.76
Role of immune cells in salt-sensitive hypertension and renal injury. Curr Opin Nephrol Hypertens (2016) 0.76
Intracellular two-phase Ca2+ release and apoptosis controlled by TRP-ML1 channel activity in coronary arterial myocytes. Am J Physiol Cell Physiol (2013) 0.76
Hypertension and immunity: mechanisms of T cell activation and pathways of hypertension. Curr Opin Nephrol Hypertens (2015) 0.76
Regulation of renin release via cyclic ADP-ribose-mediated signaling: evidence from mice lacking CD38 gene. Cell Physiol Biochem (2013) 0.75
Effector memory T lymphocytes in renal disease. Am J Physiol Renal Physiol (2010) 0.75
Endothelin receptor-specific control of endoplasmic reticulum stress and apoptosis in the kidney. Sci Rep (2017) 0.75
Characterization and Activation of NLRP3 Inflammasomes in the Renal Medulla in Mice. Kidney Blood Press Res (2016) 0.75
Inflammasome Activation in Chronic Glomerular Diseases. Curr Drug Targets (2016) 0.75
Influence of dietary NaCl on L-arginine transport in the renal medulla. Am J Physiol Regul Integr Comp Physiol (2003) 0.75